Sine Pharmaceutical Laboratories

China

Back to Profile

1-5 of 5 for Sine Pharmaceutical Laboratories Sort by
Query
Aggregations
IPC Class
A61K 35/74 - Bacteria 3
A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system 3
A61P 1/12 - Antidiarrhoeals 3
C12N 1/20 - BacteriaCulture media therefor 3
C12P 1/04 - Preparation of compounds or compositions, not provided for in groups , by using microorganisms or enzymesGeneral processes for the preparation of compounds or compositions by using microorganisms or enzymes by using bacteria 3
See more
Found results for  patents

1.

CULTURE MEDIUM FOR LACTOBACILLUS ACIDOPHILUS AND STREPTOCOCCUS FAECALIS, COMPOSITION COMPRISING THE SAME AND PREPARATION METHOD THEREOF

      
Application Number CN2008070255
Publication Number 2008/101428
Status In Force
Filing Date 2008-02-03
Publication Date 2008-08-28
Owner SINE PHARMACEUTICAL LABORATORIES (China)
Inventor
  • Chen, Binhua
  • Wang, Xuesong
  • Zhang, Liang

Abstract

A microbe composition comprising three viable and beneficial bacteria: Bifidobacterium longum, Lactobacillus acidophilus and Streptococcus faecalis. The invention further provides a method of preparing the composition with the addition of a protective medium comprising dried skimmed milk, lactulose, sodium vitamin C, sodium glutamate and starch. Furthermore, the invention provides protective medium, fermentation culture medium and seed culture medium used for the microbe composition.

IPC Classes  ?

  • A61K 35/74 - Bacteria
  • C12N 1/20 - BacteriaCulture media therefor
  • C12P 1/04 - Preparation of compounds or compositions, not provided for in groups , by using microorganisms or enzymesGeneral processes for the preparation of compounds or compositions by using microorganisms or enzymes by using bacteria
  • A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
  • A61P 1/12 - Antidiarrhoeals
  • C12R 1/32 - Mycobacterium
  • C12R 1/23 - Lactobacillus acidophilus
  • C12R 1/46 - Streptococcus

2.

CULTURE MEDIUM FOR BIFIDOBACTERIUM LONGUM, COMPOSITION COMPRISING THE SAME AND PREPARATION METHOD THEREOF

      
Application Number CN2008070254
Publication Number 2008/098503
Status In Force
Filing Date 2008-02-03
Publication Date 2008-08-21
Owner SINE PHARMACEUTICAL LABORATORIES (China)
Inventor
  • Chen, Binhua
  • Wang, Xuesong
  • Zhang, Liang

Abstract

A microbe composition comprising three viable and beneficial bacteria: Bifidobacterium longum, Lactobacillus acidophilus and Streptococcus faecalis. The invention further provides a method of preparing the composition with the addition of a protective medium comprising dried skimmed milk, lactulose, sodium vitamin C, sodium glutamate and starch. Furthermore, the invention provides protective medium, fermentation medium and seed culture medium used for the microbe composition.

IPC Classes  ?

  • A61K 35/74 - Bacteria
  • C12N 1/20 - BacteriaCulture media therefor
  • C12P 1/04 - Preparation of compounds or compositions, not provided for in groups , by using microorganisms or enzymesGeneral processes for the preparation of compounds or compositions by using microorganisms or enzymes by using bacteria
  • A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
  • A61P 1/12 - Antidiarrhoeals
  • C12R 1/32 - Mycobacterium
  • C12R 1/23 - Lactobacillus acidophilus
  • C12R 1/46 - Streptococcus

3.

PREPARATION PROCESS OF RECOMBINANT HUMAN P43 PROTEIN

      
Application Number CN2008070132
Publication Number 2008/089690
Status In Force
Filing Date 2008-01-17
Publication Date 2008-07-31
Owner SINE PHARMACEUTICAL LABORATORIES (China)
Inventor
  • Liu, Datao
  • Tan, Xiaoding
  • Hu, Linda
  • Wang, Yan
  • Zhu, Xi

Abstract

Provided is a preparation process of recombinant human p43 protein which can be served as a medicament for treating solid tumors.

IPC Classes  ?

  • C07K 1/14 - ExtractionSeparationPurification
  • C07K 1/18 - Ion-exchange chromatography
  • C07K 1/30 - ExtractionSeparationPurification by precipitation
  • C12N 15/12 - Genes encoding animal proteins

4.

PHARMACEUTICAL COMPOSITION COMPRISING P43 PROTEIN FOR THE TREATMENT OF GASTRIC ADENOCARCINOMA

      
Application Number CN2007070965
Publication Number 2008/064596
Status In Force
Filing Date 2007-10-26
Publication Date 2008-06-05
Owner SINE PHARMACEUTICAL LABORATORIES (China)
Inventor
  • Liu, Datao
  • Tan, Xiaoding
  • Zhu, Xi
  • Wang, Yan
  • Hu, Linda

Abstract

A pharmaceutical composition for the treatment of gastric adenocarcinoma is provided, wherein the pharmaceutical composition comprises p43 protein and pharmaceutically acceptable carriers, and does not comprise paclitaxel. A use of p43 protein for the treatment of gastric adenocarcinoma is also provided.

IPC Classes  ?

  • A61K 38/16 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof
  • A61P 35/00 - Antineoplastic agents

5.

NEW LACTOBACILLUS RHAMNOSUS STRAIN, ITS PHARMACEUTICAL COMPOSITION AND THE USES THEREOF, AND THE METHOD FOR PREPARATION

      
Application Number CN2007070962
Publication Number 2008/052468
Status In Force
Filing Date 2007-10-26
Publication Date 2008-05-08
Owner SINE PHARMACEUTICAL LABORATORIES (China)
Inventor
  • Zhu, Xi
  • Liu, Jing
  • Qiu, Lijun
  • Chen, Jiafeng
  • Chen, Jiao

Abstract

Lactobacillus rhamnosus strain SLR0406, which can exist for 30-60 days at 37 °C. A pharmaceutical composition comprising Lactobacillus rhamnosus strain SLR0406. The Lactobacillus rhamnosus strain SLR0406 CCTCC-M206023 according to the present application can be conserved for long term, and can be used to treat diarrhea and other related symptoms caused by antibiotics and chemotherapy medicines efficiently.

IPC Classes  ?

  • C12N 1/20 - BacteriaCulture media therefor
  • C12P 1/04 - Preparation of compounds or compositions, not provided for in groups , by using microorganisms or enzymesGeneral processes for the preparation of compounds or compositions by using microorganisms or enzymes by using bacteria
  • A61K 35/74 - Bacteria
  • A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
  • A61P 1/12 - Antidiarrhoeals
  • A61P 1/16 - Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
  • A61P 37/08 - Antiallergic agents
  • C12R 1/225 - Lactobacillus